A Phase 1 Mass Balance Study of Varegacestat

NCT06845852 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2025-09-26

No results posted yet for this study

Summary

This clinical study is designed to study the mass balance of a single dose of varegacestat in healthy male participants.

Conditions

  • Healthy Volunteer

Interventions

DRUG

varegacestat

Single oral dose of varegacestat

Sponsors & Collaborators

  • Immunome, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-25
Primary Completion
2025-03-11
Completion
2025-03-26
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06845852 on ClinicalTrials.gov